Melanoma
Rabbie R, Ansari-Pour N, Cast O, Lau D, Scott F. Khoja L … Adams DJ (2020 Aug 27;11(1):4306. doi: 10.1038/s41467-020-18060-0) Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases. Nature Communications.
Maurice C, Khoja L, Morgan E, Mason WP, Katzberg H, Pereira AM … Butler M. (2020 May 21;346:577267. doi: 10.1016/j.jneuroim.2020.577267) Guillain-Barré Syndrome following a series of novel therapies adapting the gold-standard in the era of immune priming. Journal of Neuroimmunology
Khoja L, Atenafu EG, Suciu S, Leyvraz S, Sato T, Marshall E … Joshua AM. (2019 May 31. DOI: 10.1093/annonc/mdz176) Meta-Analysis in Metastatic Uveal Melanoma to Determine Progression-Free and Overall Survival Benchmarks: an International Rare Cancers Initiative (IRCI) Ocular Melanoma study. Annals of Oncology
Nguyen LT, Saibil SD, Sotov V, Le MX, Khoja L, Ghazarian D … Butler MO. (2019 May; 68(5):773-785. doi: 10.1007/s00262-019-02307-x) Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2. Cancer Immunol Immunother.
Mathew N. Nicholas, Leila Khoja, Eshetu G. Atenafu, David Hogg, Ian Quirt, Marcus Butler and Anthony M. Joshua (2018 Dec; DOI: 10.1097/CMR.0000000000000468) Prognostic factors for first-line therapy and overall survival of metastatic uveal melanoma: The Princess Margaret Cancer Centre experience. Melanoma Research
Leila Khoja, Minnie Kibiro, Ur Metser, Craig Gedye, David Hogg, Marcus O. Butler … Anthony M. Joshua (2016 Nov 8; DOI:10.1038/bjc.2016.308) Patterns of Response to Anti-PD1 Treatment: An Exploratory Comparison of Four Radiological Response Criteria and Associations with Overall Survival in Metastatic Melanoma Patients. British Journal of Cancer
Khoja L, Atenafu EG, Templeton AJ, Ye Q, Chappell M, Saibil SD, … Joshua AM (2016 Oct; DOI: 10.1002/cam4.878). The full blood count as a biomarker of outcome and toxicity in ipilimumab treated cutaneous metastatic melanoma. Cancer Medicine
Leila Khoja, Catherine Maurice, MaryAnne Chappell, Leslie MacMillan, Ayman S Al-Habeeb, Nada Al-Faraidy … David Hogg (2016 Mar; DOI: 10.1158/2326-6066). Eosinophilic fasciitis and acute encephalopathy toxicity from pembrolizumab treatment of a patient with metastatic melanoma. Clinical Immunology Research
Leila Khoja, Eshetu G Atenafu, Qian Ye, Craig Gedye, MaryAnne Chappell, David Hogg … Anthony M. Joshua (2016 Feb; DOI: 10.3892/01.2015.4069) Real‑world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma. Oncology Letters
Khoja L, Butler MO, Chappell MA, Hogg D, Joshua AM.(2015 Aug; DOI: 10.3747/co.22.2418). Increased treatment related toxicity subsequent to an anti-PD1 agent. Current Oncology
Pitcher B, Khoja L, Hamilton RJ, Abdallah K, Pintilie M, Joshua AM (2017, Feb; DOI:10.1371/journal.pone.0170544). Assessment of Prognostic Models, PSA metrics and toxicities in Metastatic Castrate Resistant Prostate Cancer using Data from Project Data Sphere (PDS). PLOS One.
Raya Leibowitz-Amit, Melania Pintilie, Leila Khoja, Arun A. Azad, Raanan Berger, A. Douglas Laird … Anthony M. Joshua (2016 Jan 13; DOI: 10.1186/s12967-015-0747-y). Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial. Journal of Translational Medicine
Leibowitz-Amit R, Khoja L, Tannock IF, Joshua AM (2015 May; DOI: 10.1093/annonc/mdv039). Choosing a better end point for trials of bone-protective agents. Annals of Oncology
Upper Gastrointestinal and Hepatobiliary and pancreatic carcinomas
Papaxoinis G, Weaver JMJ, Khoja L, Patrao A, Stamatopoulou S, Alchawaf A, Owen-Holt V, Germetaki T, Kordatou Z, Mansoor W. (2017 May 19:1-9. DOI: 10.1080/0284186X.2017.1328127) Significance of baseline FDG-PET/CT scan as a method of staging regional lymph nodes in patients with operable distal oesophageal or gastroesophageal junction adenocarcinoma. Acta Oncologica
Gynaecological carcinomas
E. Dean, L. Khoja, A. Clamp, GC. Jayson, D. Goonetilleke, A.M. Conway, J Hasan (2017 Mar; DOI: 10.2217/fon-2016-0431). Malignant bowel obstruction in advanced ovarian cancer. Future Oncology
Khoja L, Horsley L, Heesters A, Machin JD, Mitchell C, Clamp AR, Jayson GC, Hasan J. (2016 June; DOI: 10.1136/esmoopen-2016-000057) Does Clinical Trial Participation Improve Outcomes in Ovarian Cancer Patients? ESMO Open
Leila Khoja, Katie Nolan, Rasheid Mekki, Andrea Milani, Linda Ashcroft, Jurjees Hasan … Gordon C Jayson (2016 Dec; DOI: 10.1016/j.clon.2016.06.011). Improved Survival from Ovarian Cancer in Patients Treated in Major Regional Cancer Centres in the UK; Evidence from Recent Collaborative Trials. Clinical Oncology (Royal College of Radiologists).
General translational/biomarker papers in oncology
Sung M, Zer A, Walia P, Khoja L, Maganti M, Labbe C … Leighl NB. (2020 May; DOI: 10.21037/jtd.2020.04.30) Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. Journal of Thoracic Disease.
Zer A, Sung MR, Walia P, Khoja L, Maganti M, Labbe C … Leighl NB. (2018 Sep; DOI: 10.1016/j.cllc.2018.04.008). Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non-Small-Cell Lung Cancer. Clinical Lung Cancer